Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry (v3.3.2) and omits the older entry (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T16:56:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice from the page.
    Difference
    0.5%
    Check dated 2025-11-17T15:03:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New version entry dated 2025-01-15 added to Record History, expanding the version chronology. This reflects the most recent submission and study record update.
    Difference
    0.1%
    Check dated 2025-11-03T01:32:17.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update: publish of a funding-related operating status notice and a new software version (v3.2.0) replacing v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T10:37:56.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:23:53.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now shows revision v3.0.2, replacing v3.0.1, and the 'Back to Top' element has been removed.
    Difference
    0.7%
    Check dated 2025-09-13T17:39:13.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.